Skip to main content

and
  1. Article

    Open Access

    Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada

    Every year, over 1 million people develop isoniazid (INH) resistant tuberculosis (TB). Yet, the optimal treatment regimen remains unclear. Given increasing prevalence, the clinical efficacy of regimens used by...

    Kamila Romanowski, Leslie Y. Chiang, David Z. Roth, Mel Krajden in BMC Infectious Diseases (2017)

  2. No Access

    Article

    Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings

    The risk of tuberculosis (TB) is variable among individuals with latent Mycobacterium tuberculosis infection (LTBI), but validated estimates of personalized risk are lacking. In pooled data from 18 systematically...

    Rishi K. Gupta, Claire J. Calderwood, Alexei Yavlinsky, Maria Krutikov in Nature Medicine (2020)